Gene therapy pioneer jerry r. mendell, m.d.

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today announced that time named renown neuromuscular researcher, physician and gene therapy pioneer jerry r. mendell, m.d., to the inaugural 2024 time100 health, a list of 100 individuals who most influenced global health this year. dr. mendell was recognized for his lifetime commitment to neuromuscular disease and achievements in genetic medicine that propell.
SRPT Ratings Summary
SRPT Quant Ranking